These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [A case of thymoma with an increased sensitivity to pancuronium]. Hirai T; Ito M; Abe R Nihon Kyobu Geka Gakkai Zasshi; 1990 Jun; 38(6):1059-62. PubMed ID: 2398288 [TBL] [Abstract][Full Text] [Related]
3. Stiff person syndrome and myasthenia gravis. Saravanan PK; Paul J; Sayeed ZA Neurol India; 2002 Mar; 50(1):98-100. PubMed ID: 11960163 [TBL] [Abstract][Full Text] [Related]
7. [Myasthenia gravis. Information for the anesthetist and critical care physician]. Marquardt J; Reuther P Anaesthesist; 1984 May; 33(5):207-11. PubMed ID: 6465508 [TBL] [Abstract][Full Text] [Related]
8. [Complications during treatment of patients with malignant neoplasms of the larynx with antitumor preparations]. Svetlakov MI; Kravchenko AA Zh Ushn Nos Gorl Bolezn; 1964; 24(4):10-4. PubMed ID: 4961005 [No Abstract] [Full Text] [Related]
10. Studies on the reaction of the isolated phrenic nerve diaphragm preparation of various species to certain agents causing a neuromuscular block. BERGH NP Scand J Clin Lab Invest; 1953; 5 Suppl 7():5-29. PubMed ID: 13075957 [No Abstract] [Full Text] [Related]
11. Motor end-plate differences as a determining factor in the mode of action of neuro-muscular blocking substances. CHIRCHILL-DAVIDSON HC; RICHARDSON AT Nature; 1952 Oct; 170(4328):617-8. PubMed ID: 13002382 [No Abstract] [Full Text] [Related]
12. Motor end-plate differences as a determining factor in the mode of action of neuro-muscular blocking substances. ZAIMS EF Nature; 1952 Oct; 170(4328):617. PubMed ID: 13002381 [No Abstract] [Full Text] [Related]
13. [The morphologic composition of peripheral blood following intra-arterial infusion of 5-fluorouracil and alkylating preparations in stomach cancer patients]. Chernyĭ VA Vopr Onkol; 1970 Apr; 16(4):61-4. PubMed ID: 4989339 [No Abstract] [Full Text] [Related]
14. [Changes in erythropoiesis in patients with malignant tumors of the ovaries during chemotherapy]. Bruk AA; Loskutova GP; Turbina IL Vopr Onkol; 1967; 13(12):21-3. PubMed ID: 4970401 [No Abstract] [Full Text] [Related]
15. The action of decamethonium iodide (C.10) in myasthenia gravis. CHURCHILL-DAVIDSON HC; RICHARDSON AT J Neurol Neurosurg Psychiatry; 1952 May; 15(2):129-33. PubMed ID: 14928082 [No Abstract] [Full Text] [Related]
16. Sensitivity of myasthenia gravis patients to tubocurarine and decamethonium. PELIKAN EW; TETHER JE; UNNA KR Neurology; 1953 Apr; 3(4):284-96. PubMed ID: 13054856 [No Abstract] [Full Text] [Related]